Quick filters:
Open Data
Open Code
Pre-registered
Funding Declared
COI Declared
Open Access
Clear Filters
Interleukin-18 signaling promotes activation of hepatic stellate cells in mouse liver fibrosis.
Knorr J; Kaufmann B; Inzaugarat ME; Holtmann TM; Geisler L; Hundertmark J; Kohlhepp MS; Boosheri LM; Chilin-Fuentes DR; Birmingham A; Fisch KM; Schilling JD; Loosen SH; Trautwein C; Roderburg C; Demir M; Tacke F; Hoffman HM; Feldstein AE; Wree A.
Hepatology
(Unknown)
Published: 2022
Loss of hepatic SMLR1 causes hepatosteatosis and protects against atherosclerosis due to decreased hepatic VLDL secreti…
van Zwol W; Rimbert A; Wolters JC; Smit M; Bloks VW; Kloosterhuis NJ; Huijkman NCA; Koster MH; Tharehalli U; de Neck SM; Bournez C; Fuh MM; Kuipers J; Rajan S; de Bruin A; Ginsberg HN; van Westen GJP; Hussain MM; Scheja L; Heeren J; Zimmerman P; van de Sluis B; Kuivenhoven JA.
Hepatology
(Unknown)
Published: 2022
Janus kinase 2 inhibition by pacritinib as potential therapeutic target for liver fibrosis.
Torres S; Ortiz C; Bachtler N; Gu W; Grünewald LD; Kraus N; Schierwagen R; Hieber C; Meier C; Tyc O; Joseph Brol M; Uschner FE; Nijmeijer B; Welsch C; Berres ML; Garcia-Ruiz C; Fernandez-Checa JC; Trautwein C; Vogl TJ; Zeuzem S; Trebicka J; Klein S.
Hepatology
(Unknown)
Published: 2022
Genetic predisposition to porto-sinusoidal vascular disorder: A functional genomic-based, multigenerational family stud…
Shan J; Megarbane A; Chouchane A; Karthik D; Temanni R; Romero AR; Hua H; Pan C; Chen X; Subramanian M; Saad C; Mbarek H; Mehawej C; Chouery E; Abuaqel SW; Dömling A; Remadi S; Yaghi C; Li P; Chouchane L.
Hepatology
(Unknown)
Published: 2022
Mitochondrial stress in advanced fibrosis and cirrhosis associated with chronic hepatitis B, chronic hepatitis C, or no…
Loureiro D; Tout I; Narguet S; Bed CM; Roinard M; Sleiman A; Boyer N; Pons-Kerjean N; Castelnau C; Giuly N; Tonui D; Soumelis V; El Benna J; Soussan P; Moreau R; Moreau R; Paradis V; Mansouri A; Asselah T.
Hepatology
(Unknown)
Published: 2022
Apolipoprotein F is reduced in humans with steatosis and controls plasma triglyceride-rich lipoprotein metabolism.
Deprince A; Hennuyer N; Kooijman S; Pronk ACM; Baugé E; Lienard V; Verrijken A; Dirinck E; Vonghia L; Woitrain E; Kloosterhuis NJ; Marez E; Jacquemain P; Wolters JC; Lalloyer F; Eberlé D; Quemener S; Vallez E; Tailleux A; Kouach M; Goossens JF; Raverdy V; Derudas B; Kuivenhoven JA; Croyal M; van de Sluis B; Francque S; Pattou F; Rensen PCN; Staels B; Haas JT.
Hepatology
(Unknown)
Published: 2022
Circulating TREM2 as a noninvasive diagnostic biomarker for NASH in patients with elevated liver stiffness.
Indira Chandran V; Wernberg CW; Lauridsen MM; Skytthe MK; Bendixen SM; Larsen FT; Hansen CD; Grønkjær LL; Siersbæk MS; Caterino TD; Detlefsen S; Møller HJ; Grøntved L; Ravnskjaer K; Moestrup SK; Thiele MS; Krag A; Graversen JH.
Hepatology
(Unknown)
Published: 2022
IL-31 levels correlate with pruritus in patients with cholestatic and metabolic liver diseases and is farnesoid X recep…
Xu J; Wang Y; Khoshdeli M; Peach M; Chuang JC; Lin J; Tsai WW; Mahadevan S; Minto W; Diehl L; Gupta R; Trauner M; Patel K; Noureddin M; Kowdley KV; Gulamhusein A; Bowlus CL; Huss RS; Myers RP; Chung C; Billin AN.
Hepatology
(Unknown)
Published: 2022
Progressive cholestasis and associated sclerosing cholangitis are frequent complications of COVID-19 in patients with c…
Hartl L; Haslinger K; Angerer M; Semmler G; Semmler G; Schneeweiss-Gleixner M; Jachs M; Simbrunner B; Bauer DJM; Eigenbauer E; Strassl R; Breuer M; Kimberger O; Laxar D; Lampichler K; Halilbasic E; Stättermayer AF; Ba-Ssalamah A; Mandorfer M; Scheiner B; Reiberger T; Trauner M.
Hepatology
(Unknown)
Published: 2022
Metabolic reprogramming of the intestinal microbiome with functional bile acid changes underlie the development of NAFL…
Smirnova E; Muthiah MD; Narayan N; Siddiqui MS; Puri P; Luketic VA; Contos MJ; Idowu M; Chuang JC; Billin AN; Huss RS; Myers RP; Boyett S; Seneshaw M; Min HK; Mirshahi F; Sanyal AJ.
Hepatology
(Unknown)
Published: 2022
Risk of cardiovascular disease and loss in life expectancy in NAFLD.
Hepatology
(Unknown)
Published: 2022
Preliminary evidence of safety and tolerability of atezolizumab plus bevacizumab in patients with hepatocellular carcin…
D'Alessio A; Fulgenzi CAM; Nishida N; Schönlein M; von Felden J; Schulze K; Wege H; Gaillard VE; Saeed A; Wietharn B; Hildebrand H; Wu L; Ang C; Marron TU; Weinmann A; Galle PR; Bettinger D; Bengsch B; Vogel A; Balcar L; Scheiner B; Lee PC; Huang YH; Amara S; Muzaffar M; Naqash AR; Cammarota A; Personeni N; Pressiani T; Sharma R; Pinter M; Cortellini A; Kudo M; Rimassa L; Pinato DJ.
Hepatology
(Unknown)
Published: 2022
Risk of variceal hemorrhage and pretransplant mortality in children with biliary atresia.
Bass LM; Ye W; Hawthorne K; Leung DH; Murray KF; Molleston JP; Romero R; Karpen S; Rosenthal P; Loomes KM; Wang KS; Squires RH; Miethke A; Ng VL; Horslen S; Kyle Jensen M; Sokol RJ; Magee JC; Shneider BL; ChiLDReN.
Hepatology
(Unknown)
Published: 2022